Promotie onderzoek

Dit project onderzoekt de effectiviteit en toepasbaarheid van verschillende technologische interventies.

Identificeren van biomarkers, waaronder genetische variaties, die geassocieerd zijn met de effectiviteit en toxiciteit van platinumhoudende chemotherapie in de behandeling van patiënten met niet-kleincellig longcarcinoom.

The aim of this project is to provide insight in the use of biologicals, including biosimilars, in clinical practice and add to the safe and effective use of these agents. We also provide guidance on the implementation of biosimilars in clinical practice from the perspective of different stakeholders including prescribers, pharmacists and patients.

1. The safety of short hydration during cisplatin chemoradiation in head and neck cancer patients: a randmized controlled trial.
2. The feasibility of 6 monthly gosereline injections in prostate cancer patients. 
3. Nivolumab administration through an elastomeric pump versus iv bag administration: a patient preference study.